{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T12:33:30Z","timestamp":1723120410164},"reference-count":26,"publisher":"Akademiai Kiado Zrt.","issue":"43","license":[{"start":{"date-parts":[[2021,10,24]],"date-time":"2021-10-24T00:00:00Z","timestamp":1635033600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["akjournals.com"],"crossmark-restriction":true},"short-container-title":["OH"],"published-print":{"date-parts":[[2021,10,24]]},"abstract":"<jats:p><jats:bold>\u00d6sszefoglal\u00f3.<\/jats:bold>\n                    <jats:italic>Bevezet\u00e9s:<\/jats:italic> A koronav\u00edrus-2 \u00e1ltal okozott fert\u0151z\u00e9sek igen\n                    gyakran s\u00falyos, akut l\u00e9gz\u0151szervi k\u00e1rosod\u00e1s kialakul\u00e1s\u00e1hoz vezetnek, melynek\n                    k\u00f6vetkezt\u00e9ben l\u00e9gz\u00e9si el\u00e9gtelens\u00e9g manifeszt\u00e1l\u00f3dik. A pneumoni\u00e1k kialakul\u00e1s\u00e1nak\n                    kezdete (2019. december) \u00f3ta igen sok beteg szorult k\u00f3rh\u00e1zi kezel\u00e9sre. A s\u00falyos\n                    t\u00fcd\u0151gyullad\u00e1sok ell\u00e1t\u00e1sa sor\u00e1n igazol\u00f3dott, hogy a l\u00e9gz\u0151szervi gyullad\u00e1sos\n                    folyamatok sor\u00e1n a betegek jelent\u0151s r\u00e9sz\u00e9ben v\u00e9n\u00e1s, ritk\u00e1bban art\u00e9ri\u00e1s\n                    thrombosisok alakulnak ki, tov\u00e1bb s\u00falyosb\u00edtva a klinikai \u00e1llapotot.\n                        <jats:italic>C\u00e9lkit\u0171z\u00e9s:<\/jats:italic> A 2020. szeptember \u00e9s 2021. m\u00e1rcius k\u00f6z\u00f6tti\n                    id\u0151szakban 1590, koronav\u00edrus-2 \u00e1ltal megfert\u0151z\u00f6tt, t\u00fcd\u0151gyullad\u00e1ssal sz\u00f6v\u0151d\u00f6tt\n                    beteget l\u00e1ttunk el oszt\u00e1lyunkon. Betegeinkben azt vizsg\u00e1ltuk, hogy milyen\n                    jelleg\u0171 \u00e9s ar\u00e1ny\u00fa a thromboemboli\u00e1s sz\u00f6v\u0151dm\u00e9nyek el\u0151fordul\u00e1sa.\n                        <jats:italic>M\u00f3dszer:<\/jats:italic> Az 1590, koronav\u00edrus-2 \u00e1ltal fert\u0151z\u00f6tt beteg\n                    mindegyik\u00e9ben meghat\u00e1roztuk a pneumonia s\u00falyoss\u00e1g\u00e1t; klinikai gyan\u00fa eseteiben\n                    als\u00f3 v\u00e9gtagi Doppler-ultrahangvizsg\u00e1latot, valamint komputertomogr\u00e1fi\u00e1val\n                    v\u00e9gzett t\u00fcd\u0151angiogr\u00e1fi\u00e1t v\u00e9gezt\u00fcnk. <jats:italic>Eredm\u00e9nyek:<\/jats:italic> A k\u00e9palkot\u00f3\n                    vizsg\u00e1latok eredm\u00e9nyei azt igazolt\u00e1k, hogy a koronav\u00edrus-2 \u00e1ltal okozott\n                    t\u00fcd\u0151gyullad\u00e1ssal kezeltekben 13%-os gyakoris\u00e1ggal fordult el\u0151 m\u00e9lyv\u00e9n\u00e1s\n                    thrombosis; akut t\u00fcd\u0151emboli\u00e1t a betegek 17%-\u00e1ban k\u00f3rism\u00e9zt\u00fcnk.\n                        <jats:italic>K\u00f6vetkeztet\u00e9s:<\/jats:italic> A koronav\u00edrus-2 \u00e1ltal okozott fert\u0151z\u00e9sekben\n                    els\u0151sorban a t\u00fcd\u0151ben, de egy\u00e9b szervekben is (sz\u00edv, vese, m\u00e1j) s\u00falyos\n                    gyullad\u00e1ssal j\u00e1r\u00f3 k\u00f3rfolyamatok alakulhatnak ki, amelyek hat\u00e1s\u00e1ra fokozott\n                    thrombosisk\u00e9szs\u00e9g jelentkezik a gyullad\u00e1sos \u00e9s koagul\u00e1ci\u00f3s rendszer interakci\u00f3ja\n                    k\u00f6vetkezt\u00e9ben. A fokozott thrombosishajlam v\u00e9geredm\u00e9nyek\u00e9nt v\u00e9n\u00e1s \u00e9s ritk\u00e1bban\n                    art\u00e9ri\u00e1s thrombosisok kialakul\u00e1sa s\u00falyosb\u00edtja a betegek klinikai \u00e1llapot\u00e1t, s\n                    kedvez\u0151tlen hat\u00e1st gyakorol az \u00e9letkil\u00e1t\u00e1sra. Orv Hetil. 2021; 162(43):\n                    1710\u20131716.<\/jats:p>\n                <jats:p><jats:bold>Summary.<\/jats:bold>\n                    <jats:italic>Introduction:<\/jats:italic> The infections caused by coronavirus-2 very often\n                    lead to severe, acute respiratory damages, because of which respiratory\n                    insufficiency is manifested. As a result, since the development of pneumonias\n                    (December, 2019), many patients have required hospitalization. When treating the\n                    severe pneumonia cases, it was proved that in a significant number of patients\n                    with respiratory inflammatory processes, venous, less often arterial thrombosis\n                    occured, making the clinical state even more severe. <jats:italic>Objective:<\/jats:italic>\n                    We treated 1590 coronavirus-2 infected, pneumonia-connected patients between\n                    September, 2020 and March, 2021 at our department. We examined the nature and\n                    the proportion of the thromboembolic complications. <jats:italic>Method:<\/jats:italic> We\n                    determined the severity of pneumonia in the 1950 coronavirus-2 infected\n                    patients; when clinically suspected, they had lower limb Doppler ultrasound\n                    examination and angiography carried out with computer tomograph.\n                        <jats:italic>Results:<\/jats:italic> The result of imaging examinations proved that in\n                    13% of cases deep vein thrombosis occured; in 17% of cases acute pulmonary\n                    embolia occured with pneumonia caused by coronavirus-2.\n                        <jats:italic>Conclusion:<\/jats:italic> In coronavirus-2 infected cases, mainly in the\n                    lung, but also in other organs (heart, kidney, liver), severe inflammatory\n                    disease-processes may occur, as a result of which increased thrombosis tendency\n                    shows because of the ineraction of the inflammatory and coagulatory system. As a\n                    result of the increased thrombosis tendency, venous and less often arterial\n                    thrombosis worsen the clinical state of patients, and have unfavourable effect\n                    on life expectancy. Orv Hetil. 2021; 162(43): 1710\u20131716.<\/jats:p>","DOI":"10.1556\/650.2021.32342","type":"journal-article","created":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T13:23:11Z","timestamp":1639401791000},"page":"1710-1716","update-policy":"http:\/\/dx.doi.org\/10.1556\/policypage.crossmark.crossref.1","source":"Crossref","is-referenced-by-count":2,"title":["Thromboemboli\u00e1s sz\u00f6v\u0151dm\u00e9nyek COVID\u201319-betegekben"],"prefix":"10.1556","volume":"162","author":[{"given":"G\u00e9za","family":"Boz\u00f3ky","sequence":"first","affiliation":[{"name":"B\u00e1cs-Kiskun Megyei Oktat\u00f3k\u00f3rh\u00e1z, T\u00fcd\u0151belgy\u00f3gy\u00e1szati Oszt\u00e1ly, Kecskem\u00e9t, Ny\u00edri \u00fat 38., 6000"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9va","family":"Ruby","sequence":"additional","affiliation":[{"name":"B\u00e1cs-Kiskun Megyei Oktat\u00f3k\u00f3rh\u00e1z, T\u00fcd\u0151belgy\u00f3gy\u00e1szati Oszt\u00e1ly, Kecskem\u00e9t, Ny\u00edri \u00fat 38., 6000"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Mohos","sequence":"additional","affiliation":[{"name":"B\u00e1cs-Kiskun Megyei Oktat\u00f3k\u00f3rh\u00e1z, T\u00fcd\u0151belgy\u00f3gy\u00e1szati Oszt\u00e1ly, Kecskem\u00e9t, Ny\u00edri \u00fat 38., 6000"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Istv\u00e1n","family":"Boz\u00f3ky","sequence":"additional","affiliation":[{"name":"B\u00e1cs-Kiskun Megyei Oktat\u00f3k\u00f3rh\u00e1z, T\u00fcd\u0151belgy\u00f3gy\u00e1szati Oszt\u00e1ly, Kecskem\u00e9t, Ny\u00edri \u00fat 38., 6000"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katalin","family":"G\u00f6cz\u0151","sequence":"additional","affiliation":[{"name":"B\u00e1cs-Kiskun Megyei Oktat\u00f3k\u00f3rh\u00e1z, K\u00f6zponti Radiol\u00f3giai Oszt\u00e1ly, Kecskem\u00e9t"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"425","reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1 Boz\u00f3ky G, Ruby \u00c9, G\u00f3h\u00e9r I, et al. Disorders of hemostatic system in patiensts with malignant disease, especially in view of venous thromboembolism. [A haemostasisrendszer k\u00f3ros ir\u00e1ny\u00fa elt\u00e9r\u00e9sei szolid malignus k\u00f3resetekben, k\u00fcl\u00f6n\u00f6s tekintettel a v\u00e9n\u00e1s thromboemboli\u00e1k kialakul\u00e1s\u00e1ra.] Orv Hetil. 2007; 148: 1691-1697. [Hungarian]","DOI":"10.1556\/oh.2007.28130"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2 Falanga A. Mechanism of hypercoagulation in malignancy and during chemotherapy. Haemostasis 1998; 28(Suppl 3): 50-60.","DOI":"10.1159\/000022405"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3390\/cancers10100380","article-title":"Cancer-associated thrombosis: an overview of mechanism, risk factors, and treatment","volume":"10","author":"3 Abdol Razak","year":"2018","unstructured":"3 Abdol Razak NB, Jones G, Bhandari M, at al. Cancer-associated thrombosis: an overview of mechanism, risk factors, and treatment. Cancers (Basel) 2018; 10: 380.","journal-title":"Cancers (Basel)"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4 Aujesky D, Fine MJ. The pneumonia severity index: a decade after the initial derivation and validation. Clin Infect Dis. 2008; 47(Suppl 3): S133-S139.","DOI":"10.1086\/591394"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"2001608","DOI":"10.1183\/13993003.01608-2020","article-title":"Thrombosis and COVID-19 pneumonia: the clot thickens","volume":"56","author":"5 Price","year":"2020","unstructured":"5 Price LC, McCabe C, Garfield B, et al. Thrombosis and COVID-19 pneumonia: the clot thickens. Eur Respir J. 2020; 56: 2001608.","journal-title":"Eur Respir J"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.thromres.2020.04.024","article-title":"Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy","volume":"191","author":"6 Lodigiani","year":"2020","unstructured":"6 Lodigiani C, Iapichino G, Carenzo L, et al. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res. 2020; 191: 9-14.","journal-title":"Thromb Res"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1007\/s10067-020-05275-1","article-title":"Thrombosis in coronavirus disease 2019 (COVID-19) through the prism of Virchow's triad","volume":"39","author":"7 Ahmed","year":"2020","unstructured":"7 Ahmed S, Zimba O, Gasparyan AY. Thrombosis in coronavirus disease 2019 (COVID-19) through the prism of Virchow's triad. Clin Rheumatol. 2020; 39: 2529-2543.","journal-title":"Clin Rheumatol"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8 Tal S, Spectre G, Kornowski R, et al. Venous thromboembolism complicated with COVID-19: what do we known so far? Acta Haematol. 2020; 143: 417-424.","DOI":"10.1159\/000508233"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12959-020-00248-5","article-title":"Incindence of thromboembolism in patients with COVID-19: systemic review and meta-analysis","volume":"18","author":"9 Boonyawat","year":"2020","unstructured":"9 Boonyawat K, Chantrathammachart P, Numthavaj P, et al. Incindence of thromboembolism in patients with COVID-19: systemic review and meta-analysis. Thrombosis J. 2020; 18: 34.","journal-title":"Thrombosis J"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10 Malas MB, Naazie IN, Elsayed N, et al. Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: a systematic review and meta-analysis. EClinicalMedicine 2020; 29-30: 100639.","DOI":"10.1016\/j.eclinm.2020.100639"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.3390\/jcm9061781","article-title":"Non-overt coagulopathy in non-ICU patients with mild to moderate COVID-19 pneumonia","volume":"9","author":"11 Mazzaccaro","year":"2020","unstructured":"11 Mazzaccaro D, Giacomazzi F, Gianetta M, et al. Non-overt coagulopathy in non-ICU patients with mild to moderate COVID-19 pneumonia. J Clin Med. 2020; 9: 1781.","journal-title":"J Clin Med"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12 Suh YJ, Hong H, Ohana M, et al. Pulmonary embolism and deep vein thrombosis in COVID 19: a systematic review and meta-analysis. Radiology 2021; 298: E70-E80.","DOI":"10.1148\/radiol.2020203557"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13 Ortega-Paz L, Capodanno D, Montalescot G, et al. Coronavirus disease 2019 associated thrombosis and coagulopathy: review of the patophysiological characteristics and implications for antithrombotic management. J Am Heart Assoc. 2021; 10: e019650.","DOI":"10.1161\/JAHA.120.019650"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"14 Chen","year":"2020","unstructured":"14 Chen Z, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; 395: 507-513.","journal-title":"Lancet"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"2001365","DOI":"10.1183\/13993003.01365-2020","article-title":"Pulmonary embolism in patients with COVID-19 pneumonia","volume":"56","author":"15 Bompard","year":"2020","unstructured":"15 Bompard F, Monnier H, Saab I, at al. Pulmonary embolism in patients with COVID-19 pneumonia. Eur Respir J. 2020; 56: 2001365.","journal-title":"Eur Respir J"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"16 Tang","year":"2020","unstructured":"16 Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020; 18: 844-847.","journal-title":"J Thromb Haemost"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/jth.14810","article-title":"ISTH interim guidance on recognition and management of coagulopathy in COVID-19","volume":"18","author":"17 Thachil","year":"2020","unstructured":"17 Thachil J, Tang N, Gando S, et al. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost. 2020; 18: 1023-1026.","journal-title":"J Thromb Haemost"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18 Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497-506. [Erratum: Lancet 2020; 395: 496.]","DOI":"10.1016\/S0140-6736(20)30183-5"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19 Vadukul P, Sharma DS, Vincent P. Massive pulmonary embolism following recovery from COVID-19 infection: inflammation, thrombosis and the role of extended thrombopropylaxis. BMJ Case Rep. 2020; 13: e238168.","DOI":"10.1136\/bcr-2020-238168"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristic of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention","volume":"323","author":"20 Wu","year":"2020","unstructured":"20 Wu Z, McGoogan JM. Characteristic of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020; 323: 1239-1242.","journal-title":"JAMA"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1111\/jth.14830","article-title":"Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia","volume":"18","author":"21 Cui","year":"2020","unstructured":"21 Cui S, Chen S, Li X, et al. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost. 2020; 18: 1421-1424.","journal-title":"J Thromb Haemost"},{"key":"ref21","unstructured":"22 Gad\u00f3 K, Domj\u00e1n Gy. COVID-19 and the haemostatic system. [A COVID-19 \u00e9s a v\u00e9ralvad\u00e1s.] Orvostov\u00e1bbk Szle. 2020; 27: 50-54."},{"key":"ref22","unstructured":"23 Boz\u00f3ky G, Ruby \u00c9. Acute silent non-massive (submassive) pulmonary embolism. Am J Angiol Surg. 2018; 1: 001-003."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1182\/blood.2020006000","article-title":"COVID-19 and its implications for thrombosis and anticoagulation","volume":"135","author":"Connors JM","year":"2020","unstructured":"24 Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood 2020; 135: 2033-2040.","journal-title":"Blood"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25 Hariri LP, North CM, Shih AR, et al. Lung histopathology in COVID-19 as compared with severe acute respiratory sydrome and H1N1 influenza: a systemic review. Chest 2021; 159: 73-84.","DOI":"10.1016\/j.chest.2020.09.259"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"26 Greene MT, Spyropoulus AC, Chopra V, et al. Validation of risk assessment models of venous thromboembolism in hospitalized medical patients. Am J Med. 2016; 129: 1001.e9-1001.e18.","DOI":"10.1016\/j.amjmed.2016.03.031"}],"container-title":["Orvosi Hetilap"],"original-title":[],"link":[{"URL":"https:\/\/akjournals.com\/view\/journals\/650\/162\/43\/article-p1710.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/akjournals.com\/downloadpdf\/journals\/650\/162\/43\/article-p1710.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/akjournals.com\/downloadpdf\/journals\/650\/162\/43\/article-p1710.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T13:03:50Z","timestamp":1698411830000},"score":1,"resource":{"primary":{"URL":"https:\/\/akjournals.com\/view\/journals\/650\/162\/43\/article-p1710.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,24]]},"references-count":26,"journal-issue":{"issue":"43"},"URL":"https:\/\/doi.org\/10.1556\/650.2021.32342","relation":{},"ISSN":["0030-6002","1788-6120"],"issn-type":[{"value":"0030-6002","type":"print"},{"value":"1788-6120","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,24]]}}}